Voglivil 0.3mg Tablet
Marketer
Fibovil Pharmaceuticals Pvt Ltd
Salt Composition
Voglibose (0.3mg)
Overview Voglivil 0.3mg Tablet
Diabetac 0.3mg tablets manage type 2 diabetes by regulating post-prandial hyperglycemia. This medication is prescribed when dietary modifications and other similar treatments prove insufficient in controlling elevated blood glucose. Diabetac 0.3mg tablets should be administered immediately before meals; dosage and frequency are determined individually by your physician to optimize blood sugar control. Discontinuation requires medical supervision, as abrupt cessation may lead to dangerously high blood sugar, potentially resulting in severe complications including renal impairment and vision loss. This medication forms part of a comprehensive treatment plan including diet, exercise, and weight management as directed by your doctor; regular blood glucose monitoring is essential. Common adverse effects encompass flatulence, abdominal discomfort, anorexia, constipation, and diarrhea. Report persistent or troublesome side effects to your doctor. While Diabetac 0.3mg tablets alone do not induce hypoglycemia, concurrent use with other antidiabetic agents (especially insulin or sulfonylureas) may increase this risk. Treat hypoglycemic episodes with dextrose; sucrose is ineffective in this context. Inform your physician of any hepatic or renal dysfunction prior to commencing treatment. This medication is contraindicated in patients with bowel inflammation or ulceration (e.g., ulcerative colitis or Crohn's disease). Pregnant or lactating individuals should seek medical counsel before use. Always disclose all other medications to ensure safe usage. Limit alcohol consumption to minimize the risk of hypoglycemia.
Uses of Voglivil 0.3mg Tablet
Managing type 2 diabetes
Major Benefits of Voglivil 0.3mg Tablet:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Voglivil 0.3mg Tablet on an empty stomach.
Common Side effects of Voglivil 0.3mg Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Voglivil 0.3mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Voglivil 0.3mg Tablet on an empty stomach.
How Voglivil 0.3mg Tablet works:
Diabetics may use Voglivil 0.3mg tablets to manage their condition. These tablets work by blocking the enzymes in the intestines that digest complex carbohydrates. This action helps prevent post-meal spikes in blood sugar.
SAFETY ADVICE
AlcoholUNSAFE
Combining Voglivil 0.3mg Tablet with alcohol is inadvisable.
PregnancySAFE IF PRESCRIBED
Use of Voglivil 0.3mg tablets during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; yet, data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Voglivil 0.3mg tablets safely. Available human data indicates minimal infant risk from the medication.
DrivingSAFE
Driving ability is typically unaffected by Voglivil 0.3mg tablets.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Voglivil 0.3mg tablets. Dosage modification of Voglivil 0.3mg tablets may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Voglivil 0.3mg tablets. Dosage modification for Voglivil 0.3mg tablets may be necessary. Physician consultation is advised.
What if you forget to take Voglivil 0.3mg Tablet :
Omit any missed Voglivil 0.3mg Tablet dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About Voglivil 0.3mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Action Class | Alpha-glucosidase inhibitors |



